The role of protein phosphorylation in beta amyloid toxicity

Brain Research

Volumn 765, Issue 1, 1997, Pages 159-163

  Tan, Shirlee ^a   Maher, Pamela ^b   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Amyloid beta (A ); Cytotoxicity; Phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; ENZYME ACTIVITY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BIOTRANSFORMATION; CELLS, CULTURED; CEREBRAL CORTEX; CLONE CELLS; ENZYME INHIBITORS; KINETICS; NEUROTOXINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RATS;

EID: 0030809628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00477-0     Document Type: Article

References (27)

1. Ahn N.G., Krebs E.G. Evidence for an epidermal growth factor-stimulated protein kinase activity by myelin basic protein kinases in vitro. J. Biol. Chem. 265:1990;11495-11501.
2. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
3. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
4. Cohen P. The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions. Eur. J. Biochem. 34:1973;453-508.
5. Cohen P. The structure and regulation of protein phosphatases. Ann. Rev. Biochem. 58:1989;453-508.
6. Enan E., Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem. Pharmacol. 43:1992;1777-1784.
7. Garver T.D., Harris K.A., Lehman R.A., Lee V.M., Trojanowski J.Q., Billingsley M.L. Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J. Neurochem. 63:1994;2279-2287.
8. Glenn G. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation. J. Virol. 67:1993;1945-1952.
9. Gong C.-X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61:1993;921-927.
10. Goodman E.B., Tenner A.J. Signal transduction mechanisms of C1q-mediated superoxide production. Evidence for the involvement of temporally distinct staurosporine-insensitive and sensitive pathways. J. Immuno. 148:1992;3920-3928.
11. Goodman Y., Mattson M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 66:1996;869-872.
12. Honkanen R.E., Dukelow M., Zwiller J., Moore R.E., Khatra B.S., Boynton A.L. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Molec. Pharm. 40:1991;577-583.
13. Knauer M.F., Soreghan B., Burdick D., Kosmoski J., Glabe C.G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. USA. 89:1992;7437-7441.
14. Kopke E., Tung Y.-C., Shaikh S., Alonso A., Del C., Iqbal K., Grundke I.-I. Microtubule associated protein Tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer's disease. J. Biol. Chem. 268:1993;24374-24384.
15. Lambert M.P., Stevens G., Sabo S., Barber K., Wang G.W., Krafft G., Snyder S., Holzman T.F., Klein W.L. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39:1994;377-385.
16. Lee V.M. Disruption of the cytoskeleton in Alzheimer's disease. Cur. Opin. Neurobiol. 5:1995;663-668.
17. Luo Y.Q., Hirashima N., Li Y.H., Alkon D.L., Sunderland T., Etcheberrigaray R., Wolozin B. Physiological levels of beta-amyloid increase tyrosine phosphorylation and cytosolic calcium. Brain Res. 681:1995;65-74.
18. Maher P. Activation of phosphotyrosine phosphatase activity by reduction of cell-substrate adhesion. Proc. Natl. Acad. Sci. USA. 90:1993;11177-11181.
19. Sagara Y., Dargusch R., Schubert D., Behl C. Increased antioxidant enzyme activity Aβ resistant cells. J. Neurosci. 16:1996;497-505.
20. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;1989-1993.
21. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Steinbach J.H., Culp W., Brandt B.L. Clonal cell lines from the rat central nervous system. Nature. 249:1974;224-227.
22. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
23. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;7789-7793.
24. Yan S.D., Chan X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-719.
25. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
26. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 25:1990;279-282.
27. Zhang C., Lambert M.P., Bunch J.C., Barber K., Wade W.S., Krafft G.A., Klein W.L. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A-beta peptide. J. Biol. Chem. 269:1994;25247-25250.